Skip to content

RCT Comparing the DEXA Results of the HA-Omnifit Versus the Symax Uncemented Hip Stem

A Randomized Comparative Study to Evaluate the Performance and Confirm the Safety of the Diocom Hip Syhstem in Cementless Hip Arthroplasty

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01695213
Enrollment
50
Registered
2012-09-27
Start date
2003-04-30
Completion date
2009-07-31
Last updated
2012-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Osteoarthritis of the Hip Joint Elligable for a Uncemented Hipprosthesis

Keywords

uncemented hip, bone remodeling, DEXA, clinical evaluation

Brief summary

Thr purpose of this study is to compare the clinical and radiological results, as well as the femur bone density measurements of two uncemented total hip prostheses during 5 years of follow up.

Detailed description

It is of great importance for the function of uncemented total hip arthroplasty that the anchorage of the prosthesis in the bone of the femur is sufficient. This is of great importance in the prevention of stress shielding of the bone and to insure tranfer of forces from the prosthesis to the femur. The symax hip stem is developed to optimize stress tranfer to bone and insure mechanical stability. In this study the symax hip stem is compared to the HA\_Omnifit hip stem (a frequently used and long term evaluated uncemented hip prosthesis) During the fist two years of follow up DEXA mesurments of bone mineral density are performed. Also patient satisfaction, patient fuction score and radiological evaluation measurements are done during 5 years of follow up. Our primary objective is: comparison of the short term bone remodelling surrounding the Symax hip stem to the short term remodeling surrounding the Stryker Omnifit HA hip stem measured by bone densitometry, clinical and radiographic evaluation.

Interventions

PROCEDUREuncemented total hip arthroplasty

Sponsors

Stryker Orthopaedics
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Male or non pregnant female patients \>18 years * Patient with degenerative or traumatic changes to hip requiring hip replacement * Patient with BMI\<35 * Patient signed informed consent

Exclusion criteria

* chronic anti-inflammatory medication use\> 3 months * revision surgery to the affected femur * Cancer therapy including immunosuppression, chemotherapy and radiation * Pathological fractures, delayed ossification or non-union is likely to occur

Design outcomes

Primary

MeasureTime frameDescription
short term bone remodeling6 times within 2 yearsBone remodeling is determined by measuring the Bone mineral density during time
complications and reoperationsduring 5 yearsReporting all complications and reoperations of the two different hip prostheses

Secondary

MeasureTime frameDescription
clinical performance9 times within 5 yearsComparison of the clinical performance of the two different hip prostheses
Radiological evaluation9 times within 5 yearsEvaluation of Xrays according to the engh classifications

Other

MeasureTime frameDescription
patient satisfaction9 times within 5 yearscomparison of patient satisfaction between the two different prostheses

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026